Medline completes $2.68 billion secondary stock offering

Medline Inc. (NASDAQ: MDLN) completed a secondary offering of 72.6 million shares of Class A common stock at $37.00 per share, the company announced. The offering was conducted by selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a subsidiary of the Abu Dhabi Investment Authority.

The transaction generated approximately $2.68 billion in gross proceeds for the selling stockholders. Medline did not sell any shares in the offering and received no proceeds from the sale.

The selling stockholders granted underwriters a 30-day option to purchase up to an additional 10.9 million shares of Medline's Class A common stock.

Goldman Sachs & Co. LLC, Morgan Stanley, BofA Securities and J.P. Morgan served as global coordinators and joint bookrunning managers for the offering. Multiple other financial institutions participated as bookrunning managers and co-managers.

The securities were offered through a prospectus, with a registration statement filed with and declared effective by the Securities and Exchange Commission.

Medline describes itself as the largest provider of medical-surgical products and supply chain solutions serving healthcare facilities. The Northfield, Illinois-based company employs more than 45,000 people worldwide and operates in more than 100 countries.

You May Also Be Interested In

• Definium Therapeutics plans $500M public share offering
• Gores Holdings XI prices $312M IPO on Nasdaq
• ITG launches IPO roadshow, seeks Nasdaq listing at up to $22 per share